AngioDynamics/ANGO

$5.79

-3.33%
-
1D1W1MYTD1YMAX

About AngioDynamics

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Ticker
ANGO
Sector
Healthcare
Trading on
NASDAQ
Industry
Medical Equipment & Supplies
CEO
James Clemmer
Employees
815
Headquarters
Latham, United States

AngioDynamics Metrics

BasicAdvanced
$230.76M
Market cap
-
P/E ratio
-$0.36
EPS
0.67
Beta
-
Dividend rate

What the Analysts think about AngioDynamics

Analyst Ratings

Majority rating from 4 analysts.
Buy

Price Targets

Average projection from 3 analysts.
159.07% upside
High $18.00
Low $10.00
$5.79
Current price
$15.00
Average price target

AngioDynamics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-36.7% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$79M
0.51%
Net income
$-29M
-163.32%
Profit margin
-36.7%
-162.99%

AngioDynamics Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 33.33%
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
-$0.03
$0.02
-$0.12
-$0.05
-
Expected
-$0.01
$0.02
-$0.13
-$0.08
-$0.14
Surprise
300%
-11.11%
-7.69%
-33.33%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell AngioDynamics stock

Buy or sell AngioDynamics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing